News
Children’s Hospital At Erlanger Introduces 2 New Neonatal/Pediatric Critical Care Transport Vehicles
The Salvation Army of Chattanooga Women’s Auxiliary is hosting their annual Ice Cream Social for the unhoused community. "The ...
Bryan Kohberger pleaded guilty to the 2022 murders that shook the University of Idaho campus. Under a plea agreement, he ...
16don MSN
Children with critical levels of malnutrition can be safely rehydrated intravenously, according to a new study that calls for a review of the existing global treatment guidelines.
Subcutaneous isatuximab administered via an on-body injector appears to be as safe and effective as intravenous isatuximab in patients with relapsed or refractory multiple myeloma.
Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
A phase 2 trial reveals that combining intratumoral BO-112 with pembrolizumab shows potential in treating anti–PD-1-resistant ...
I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...
With darting red and green beams above me and large mechanical eyes and grids humming and moving around me, I feel as though I’m in a 1950s sci-fi movie.
16d
News-Medical.Net on MSNStudy: Intravenous rehydration ‘safe’ for severely malnourished childrenChildren with critical levels of malnutrition can be safely rehydrated intravenously, according to a new study that calls for ...
16h
Zacks.com on MSNRARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year EndUltragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.
The new mother had a normal recovery from childbirth. But a month later, she was beset by debilitating symptoms.
Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results